Navigation Links
BioWa and Medarex Announce License of BioWa's COMPLEGENT(TM) Technology
Date:7/16/2008

ng or have had INDs submitted for such trials, with seven of the most advanced product candidates currently in Phase 3 clinical trials or the subject of regulatory applications for marketing authorization. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its website at http://www.medarex.com.

Medarex Statement on Cautionary Factors

Except for the historical information presented herein, matters discussed herein may constitute forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995, that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "suggests"; "potential"; or "may"; or similar statements are forward-looking statements. Medarex disclaims, however, any intent or obligation to update these forward-looking statements. These risks and uncertainties include those detailed from time to time in Medarex's public disclosure filings with the U.S. Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K for the fiscal year ended December 31, 2007 and its quarterly reports on Form 10-Q. There can be no assurance that such development efforts will succeed or that other developed products will receive required regulatory clearance or that, even if such regulatory clearance were received, such products would ultimately achieve commercial success. Copies of Medarex's public disclosure filings are available from its investor relations department.

Medarex(R), the Medarex logo and UltiMAb(R) are registered trademarks of Medarex, Inc. All rights are reserved. '/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Increased Light Leads to Early Detection: Caliper Life Sciences Introduces Bioware(R) Ultra Cancer Cell Lines
2. BioWa Announces Expansion of License Agreement with Genentech for BioWas POTELLIGENT(R) Technology
3. BioWa Announces Licensing of BioWas POTELLIGENT(R) Technology by GlaxoSmithkline for Use in Antibody Research and Development
4. Medarex Announces July 10 Live Webcast of R&D Day Event
5. Medarex to Present at the Jefferies Second Annual Healthcare Conference
6. Medarex to Present at the 29th Annual Goldman Sachs Healthcare Conference
7. Medarex to Present at the Bank of America 2008 Healthcare Conference
8. Medarex to Present at the Morgan Stanley Global Healthcare Unplugged Conference
9. Medarex Reports Phase 1/2 Clinical Data of MDX-060 in Lymphoma at American Association for Cancer Research Meeting
10. Medarex to Receive Milestone Payment from Novo Nordisk
11. Medarex Receives Milestone Payment for Submission of Regulatory Application Requesting Approval of Golimumab (CNTO 148) in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... SAN DIEGO , July 29, 2015  Pfenex ... quarter 2015 financial results will be released on Thursday, ... 8:30 am Eastern Time, Pfenex management will host a ... a business update.  A press release outlining the financial ... to the call. Please call 1-866-376-8058 (US) ...
(Date:7/29/2015)... ... July 29, 2015 , ... The third Medical Innovation Impact Index (MI3) ... in particular, drug/device combinations. The current system received a score of 0 (range -10 ... Centered Innovation (iPCI) of Fairleigh Dickinson University’s ( FDU ) Rothman Institute of ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... it has selected an optimized Erk inhibitor molecule ... the development of a new class of potential ... represents a prime target for therapeutic intervention in ... and survival benefits for B-Raf and Mek inhibitors. ...
(Date:7/29/2015)... ... 29, 2015 , ... CSSi LifeSciences™ formalized a ... in Clinical Trial Management. CSSi LifeSciences is specialized in strategic, marketing, and regulatory ... Clinical is focused on Clinical Trial Management, Clinical Site Monitoring, and Clinical Payment ...
Breaking Biology Technology:Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3
... drive somatic, or fully differentiated, human cells back to ... of the significant scientific and social challenges to the ... promise of regenerative medicine. Recent research with mouse and ... is possible, although the current process is inefficient and, ...
... Gen-Probe Incorporated,(Nasdaq: GPRO ) announced today that the ... highly specific molecular diagnostic test to detect,high-risk strains of ... HPV Assay has been CE marked and is currently ... CE marking and launch of our APTIMA HPV Assay ...
... that a live audio webcast and accompanying slide,presentation will be provided ... Prenatal Diagnostics." Details of the,event are as follows:, What: ... Diagnostics, When: Tuesday, June 3, 2008 ... http://www.sequenom.com , Agenda: Hosted by: ...
Cached Biology Technology:New insights into cellular reprogramming revealed by genomic analysis 2Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 2Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 3Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 4Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 5Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3 2
(Date:7/7/2015)... DUBLIN , June 30, 2015 ... ) has announced the addition of the ... their offering. To this date, fingerprint ... biometric technology and fingerprint sensors are well developed. ... capacitive sensing technology. The domain of ...
(Date:7/2/2015)... 25, 2015 Research ... of the "Natural Language Processing Market by ... OCR, Pattern & Image Recognition) - Worldwide Forecast ... The key vendors occupying the market are ... Microsoft Corporation, NetBase Solutions, SAS Institute Inc., Verint ...
(Date:6/30/2015)... To bolster its efforts and commitment to fighting cyber fraud, ... of two new team members. Dimitri ... Raviv will act as head of strategic alliances. These ... the most secure solutions for the enterprise market. ... a provider of security and management products, which was acquired ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... available in French . , A recent ... Human Stress (CSHS) at the Hpital Louis-H. Lafontaine and professor ... changes the structure surrounding a gene involved in regulating mood, ... age. The study published in the journal Psychological ...
... kinds than had been reported in findings published just four ... planet. Hitching rides in the upper troposphere, they,re making their ... North America.For the first time researchers have been able to ... molecular methods to samples from two large dust plumes originating ...
... travel and climate warming could be creating the right conditions ... to a new Cornell University computer model., The model predicts ... and spread by the invasive Asian tiger mosquito, could occur ... in Atlanta from June through September, and year-round in Miami. ...
Cached Biology News:Bullying by childhood peers leaves a trace that can change the expression of a gene linked to mood 2Plumes across the Pacific deliver thousands of microbial species to West Coast 2Plumes across the Pacific deliver thousands of microbial species to West Coast 3Chances seen rising for chikungunya outbreaks in NYC, Atlanta, Miami 2
Rat Aortic Endothelial Cells (RAOEC) (>500,000 cells)...
...
... suitable for use with a wide range ... to water and some of the higher ... of removing water and organic solvents from ... microplates, vials and round bottom flasks; making ...
... The H2OBIT™ is a fully licensed, high throughput, ... processing of up to 24 microplates. This equates ... plates. A robotic arm rapidly transfers ... resulting in temperature ramping times that are considerably ...
Biology Products: